Use access key #2 to skip to page content.
$12.94 -0.36 (-2.71%)
10/7/2008 3:26 PM

Crucell N.V. (ADR) (CRXL)

CAPS Rating:
****

A fully integrated biopharmaceutical company, focuses on developing, producing and marketing vaccines and antibodies against infectious diseases for private and public markets worldwide and leverage its novel, proprietary technologies.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating CRXL

Add Stock to Watchlist

What the Community Thinks

Total Members

77 Outperforms
4 Underperforms
 

All-Stars

17 Outperforms
2 Underperforms
 

Wall Street

1 Outperforms
0 Underperforms
 

Members bullish on CRXL are also bullish on:

Members bearish on CRXL are also bearish on:

Ticker Tags

Small Cap (1922), Netherlands (18), Biotechnology (295)
Suggest a tag

Crucell N.V. (ADR) At A Glance

Current Price: $12.94
Last Trade Time: 10/7/2008 3:26 PM
Open: $13.51
Previous Close: $13.30
Daily Range: $12.91 - $13.68
52-Week Range: $12.76 - $21.17
Volume: 54,368
Market Cap: $869.13M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

CRXL VS S&P 500 (SPY)

CRXL 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for CRXL

More Headlines...

Top Bull Pitch

Recs

1

Crucell N.V. (ADR) (CRXL)

Avatar dropje (63.82) Submitted: 12/08/06 4:00 PM

Dutch pride; bit speculative but promising pipeline

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 19 :   1 2 3 4 Next »

Recs

0

 (CRXL)

Avatar EclecticRecluse (74.93) Submitted: 9/29/08 9:13 AM : Outperform Start Price: $15.14 CRXL Score: 1.54

Earnings Estimates Revised Upward

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRXL)

Avatar oldnbroke441 (93.29) Submitted: 8/29/08 9:06 AM : Underperform Start Price: $16.30 CRXL Score: -2.28

stoch macd bear

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRXL)

Avatar Jdelaney634 (96.79) Submitted: 6/20/08 4:01 PM : Outperform Start Price: $16.56 CRXL Score: 2.41

This has been a frustrating stock for me. I really like this company, I like vaccines, but it seems to trade under 20. I like the price to get in to here, but they really need to make some headway in a marketable vaccine. They were operating cash flow even for a second there - some earnings would be nice. I suspect short interest pinning this dude down. I think it is pretty safe to enter at this level, but not sure of the upside potential unless we get a catalyst for growth.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRXL)

Avatar JPAHOME (33.28) Submitted: 2/21/08 11:29 AM : Outperform Start Price: $14.30 CRXL Score: 16.92

Crucell cames out with excellent quartery numbers and this vaccine mfgr. should rise quickly as a result. Its recent acquisitions also will help this Amsterdam company .

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRXL)

Avatar AvaMac (< 20) Submitted: 12/31/07 5:32 PM : Outperform Start Price: $17.13 CRXL Score: 7.27

best technology for producing vaccines, licensing to more and more drug companies, making vaccines for bird flu, rabies, etc. As more nations grow prosperous, spending for vaccines will grow.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 19 :   1 2 3 4 Next »

Wall Street

Results 1 - 1 of 1  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackNeedham < 20 11/14/07 Outperform NS $19.07-32.14%-32.96%+0.82

Results 1 - 1 of 1  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners